NCT00207259

Brief Summary

Randomized clinical study of two CAM therapies, 1) Reiki and 2) Relaxation Response Therapy with Cognitive Restructuring counseling (RRT with CR), compared to an education-only control arm in patients about to begin an eight-week course of external beam radiotherapy (EBRx) for prostate cancer. Generally, we would like to examine the feasibility of studying Reiki and RRT with CR in patients with prostate cancer, and to obtain preliminary results on the effectiveness of these treatments compared to controls. Specific objectives:

  1. 1.Determine the proportion of eligible patients who agree to participate in the study
  2. 2.Measure compliance with CAM therapy interventions
  3. 3.Measure compliance with physiologic and psychological outcome measurement assessments
  4. 4.Assess differences between experimental and control groups on measures on depression, anxiety, quality of life, salivary cortisol levels and an immunomarkers

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable prostate-cancer

Timeline
Completed

Started Mar 2005

Longer than P75 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2005

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 21, 2005

Completed
11.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2017

Completed
Last Updated

July 13, 2017

Status Verified

July 1, 2017

Enrollment Period

12.3 years

First QC Date

September 13, 2005

Last Update Submit

July 11, 2017

Conditions

Keywords

Prostate CancerReikiRelaxation ResponseCognitive RestructuringFeasibility

Outcome Measures

Primary Outcomes (1)

  • Obtain preliminary results on the effectiveness of these treatments compared to controls

    QOL testing performed at four time points

    Measurements taken at multiple time points

Study Arms (3)

Control

NO INTERVENTION

Standard weekly treatments with radiation oncologist and nurse. All control patients offered intervention at end of 8-week course of radiotherapy.

Relaxation Therapy

EXPERIMENTAL

Weekly relaxation therapy with PhD psychologist and home cognitive restructering practice

Behavioral: Reiki & Relaxation Response Therapy with Cognitive Restructuring

Reiki

EXPERIMENTAL

Weekly Reiki therapy with a Reiki therapist, involves laying of the therapist's hands on the patient to rechannel energy, considered pleasant and calming

Behavioral: Reiki & Relaxation Response Therapy with Cognitive Restructuring

Interventions

Relaxation Therapy: Practice of focus on breathing or repeated word while ignoring random thoughts without bias. Designed to lower heart rate, blood pressure and stress. Reiki: Practice of laying on hands by a Reiki therapist in order to channel patient's energy, considered calming and pleasant.

Also known as: Relaxation Therapy, Reiki therapy
ReikiRelaxation Therapy

Eligibility Criteria

Age30 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 30
  • Histologic documentation of prostate cancer (no time limit)
  • Gleason score assignment is mandatory prior to entry
  • ECOG Performance Status of 0, 1, or 2
  • Clinical Stage Tl - T4 adenocarcinoma of the prostate
  • Planned androgen suppression therapy prior to an eight-week course of external beam radiotherapy
  • Signed Informed Consent

You may not qualify if:

  • Prior pelvic radiotherapy
  • Evidence of metastatic disease
  • Currently receiving ongoing psychotherapy or antidepressive medications
  • Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Therapeutic TouchCognitive RestructuringRelaxation Therapy

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Clair Beard, MD

    Dana-Farber Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Physician, Vice-Chair, Genitourinary Radiaton Oncology

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 21, 2005

Study Start

March 1, 2005

Primary Completion

June 15, 2017

Study Completion

June 15, 2017

Last Updated

July 13, 2017

Record last verified: 2017-07

Locations